Authors: MCCLUNG M WASNICH R HOSKING D RAVN P REDA C FREEDHOLM D DAIFOTIS A

Citation: M. Mcclung et al., SAFETY OF ORAL ALENDRONATE 5 MG IN OSTEOPOROSIS PREVENTION, Journal of bone and mineral research, 12, 1997, pp. 464-464

Authors: SAAG K EMKEY R GRUBER B TESSER J LANE N YANOVER M DUBOIS C FREEDHOLM D CAROFANO W DAIFOTIS A

Citation: K. Saag et al., ALENDRONATE FOR THE MANAGEMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS- RESULTS OF THE MULTICENTER US STUDY, Arthritis and rheumatism, 40(9), 1997, pp. 630-630

Authors: GRASING K MURPHY MG LIN JI SWIGAR M FREEDHOLM D CLARKE L ZHANG J WOLKOWITZ OM WEINGARTNER H PUTNAM K SEIBOLD JR

Citation: K. Grasing et al., HUMAN PHARMACOKINETICS AND TOLERABILITY OF L-365,260, A NOVEL CHOLECYSTOKININ-B ANTAGONIST, Journal of clinical pharmacology, 36(4), 1996, pp. 292-300

Authors: DEGROEN PC LUBBE DF HIRSCH LJ DAIFOTIS A STEPHENSON W FREEDHOLM D PRYORTILLOTSON S SELEZNICK MJ PINKAS H WANG KK

Citation: Pc. Degroen et al., ESOPHAGITIS ASSOCIATED WITH THE USE OF ALENDRONATE, The New England journal of medicine, 335(14), 1996, pp. 1016-1021

Authors: GOEMAERE S ADACHI J HAWKINS F LANE N POUBELLE P SAAG K SCHNITZER T MALICE MP FREEDHOLM D CZACHUR M DAIFOTIS A

Citation: S. Goemaere et al., NONVERTEBRAL FRACTURE AND BONE-DENSITY IN GLUCOCORTICOID-TREATED PATIENTS, Arthritis and rheumatism, 39(9), 1996, pp. 371-371

Authors: GRASING K FREEDHOLM D MURPHY MG SWIGAR M RUSSER T NOSHER J LIN J FRAME V CLARKE L SEIBOLD JR

Citation: K. Grasing et al., SELECTIVE BLOCKADE OF CHOLECYSTOKININ TYPE-B RECEPTORS WITH L-365,260DOES NOT IMPAIR GALLBLADDER CONTRACTION IN NORMAL HUMANS, The American journal of gastroenterology, 91(3), 1996, pp. 569-573